Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT04316468 · ClinicalTrials.gov registry record
Cardiac Strain Using Speckle Tracking Echocardiography During Orthotopic Liver Transplantation
A clinical trial, sponsored by Mayo Clinic.
- Terminated
- Registry status
- 20
- Enrollment target
NCT04316468: Clinical Trial study, sponsored by Mayo Clinic.
NCT04316468 is a clinical trial that was terminated before completion, run by Mayo Clinic. The registered enrollment target is 20 participants. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT04316468 was terminated before completion, sponsored by Mayo Clinic.
- TERMINATED
- Registry status
- 20 participants
- Enrollment target
Study Summary
Researchers are trying to improve the understanding of systolic function of the heart at the time of liver reperfusion in patients undergoing orthotopic liver transplantation.
Primary Outcome
Evaluate the degree of change to cardiac strain using speckle tracking echocardiography
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 20 participants |
| Start Date | 2020-03-10 |
| Est. Completion | 2024-04-08 |
Why NCT04316468 stopped before completion
NCT04316468 is an observational study that tracks outcomes without assigning an intervention. The registry caps enrollment at 20 participants, a relatively small participant target.
The record links to 0 conditions, and to 0 interventions.
NCT04316468 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT04316468 about?
NCT04316468 is a clinical study titled "Cardiac Strain Using Speckle Tracking Echocardiography During Orthotopic Liver Transplantation". Researchers are trying to improve the understanding of systolic function of the heart at the time of liver reperfusion in patients undergoing orthotopic liver transplantation.
What is the current status of trial NCT04316468?
This trial is currently terminated. The enrollment target is 20 participants. The study started on 2020-03-10. Estimated completion is 2024-04-08.
Who is sponsoring clinical trial NCT04316468?
This trial is sponsored by Mayo Clinic, which has 2,844 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT00573339 · 20 participants
Cardiac Magnetic Resonance Imaging (MRI) Normal Reference Control Group Testing
- NCT00692939 · 20 participants · Phase 1
Autologous Stem Cell Transplantation for Crohn's Disease
- NCT00967785 · 20 participants · Phase 1
A Phase I Study of Mozobil in the Treatment of Patients With WHIMS
- NCT01406691 · 20 participants · Phase 4
Light Flashes to Treat Delayed Sleep Phase Disorder (DSPD)
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI